Publications by authors named "M Franti"

Skeletal muscle adaptation to external stimuli, such as regeneration following injury and hypertrophy in response to resistance exercise, are blunted with advanced age. The accumulation of senescent cells, along with defects in myogenic progenitor cell (MPC) proliferation, have been strongly linked as contributing factors to age-associated impairment in muscle adaptation. p53 plays an integral role in all these processes, as upregulation of p53 causes apoptosis in senescent cells and prevents mitotic catastrophe in MPCs from old mice.

View Article and Find Full Text PDF

It is unclear whether mitochondrial dysfunction and redox stress contribute to impaired age-related muscle regenerative capacity. Here we characterized a novel compound, BI4500, that inhibits the release of reactive oxygen species (ROS) from the quinone site in mitochondrial complex I (site I). We tested the hypothesis that ROS release from site I contributes to impaired regenerative capacity in aging muscle.

View Article and Find Full Text PDF

Systemic deletion of senescent cells leads to robust improvements in cognitive, cardiovascular, and whole-body metabolism, but their role in tissue reparative processes is incompletely understood. We hypothesized that senolytic drugs would enhance regeneration in aged skeletal muscle. Young (3 months) and old (20 months) male C57Bl/6J mice were administered the senolytics dasatinib (5 mg/kg) and quercetin (50 mg/kg) or vehicle bi-weekly for 4 months.

View Article and Find Full Text PDF

Aging is accompanied by disrupted information flow, resulting from accumulation of molecular mistakes. These mistakes ultimately give rise to debilitating disorders including skeletal muscle wasting, or sarcopenia. To derive a global metric of growing 'disorderliness' of aging muscle, we employed a statistical physics approach to estimate the state parameter, entropy, as a function of genes associated with hallmarks of aging.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of streptozotocin (STZ) on pancreatic hormone-producing islet cells to understand cellular changes in diabetes models.
  • Researchers used single-cell RNA sequencing to analyze nearly 3,000 pancreatic endocrine cells, employing various techniques for data analysis and validation.
  • Results showed that while some β-cells survived STZ treatment and adopted new characteristics, no evidence of conversion between different β-cell populations was found, suggesting limited regeneration potential in this diabetes model.
View Article and Find Full Text PDF